All in the mindfulness? Reflections on the Mindful Nation report

5259784851_6708fc11b5_b

André Tomlin considers the recommendations for health service delivery and research from the recent Mindful Nation report.

[read the full story...]

CBT plus taper may help reduce short-term benzodiazepine use

8119248181_d492e64f47_k

John Baker summarises a recent Cochrane systematic review of psychosocial interventions for benzodiazepine harmful use, abuse or dependence.

[read the full story...]

Cognitive behavioural prevention of depression in adolescents

Higher levels of cortisol were associated with higher levels of depression

Emily Stapley summarises a recent RCT of a cognitive behavioural prevention programme for young people at risk of depression.

[read the full story...]

Can higher educational attainment help lower dementia risk?

6385852693_6c1a743012_b

Raluca Lucacel summarises a recent meta-analysis of prospective cohort studies, which investigates the dose-response between education and the risk of dementia.

[read the full story...]

Computerised CBT for depression is no better than usual GP care: the REEACT trial

Last November we blogged the REEACT trial and concluded that computerised CBT for depression is no better than usual GP care.

Another debut blog today, this time from Suzanne Dash, who presents the results of the REEACT trial published last week in the BMJ. The study found limited uptake of computerised CBT by people with clinical depression and no benefit of free or commercially available cCBT packages over usual GP care.

[read the full story...]

Method switching in self-harm has implications for service design and risk management

3555151084_54be2c88a5_b

Katrina Witt publishes her debut blog on a new cohort study from the Multi-Centre Monitoring of Self-Harm Project, which investigates switching methods of self-harm at repeat episodes.

[read the full story...]

Antidepressants vs placebo for depression: forget the gap

566200801_89ede04e1f_b

Ioana Cristea considers the possible causes responsible for the apparent narrowing of the drug-placebo gap, which over the last 30 years has seen estimates of depression symptom reduction from antidepressants fall from 70% to 30%.

[read the full story...]

Collaboration, collaboration, collaboration

8678959548_21571c4bc0_b

Kirsten Lawson explores the benefits of working across professional and therapeutic boundaries, highlighted beautifully by the recent COINCIDE RCT of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease.

[read the full story...]

Is cCBT doing it for the kids, but not the adults?

7085307427_d35f27907c_k

Karina Lovell appraises the first UK RCT of computerised cognitive behavioural therapy (cCBT) for depression in children and young people, which shows a clinically meaningful improvement in depression and anxiety.

[read the full story...]

Integrated treatment for first episode psychosis: media hype versus reality

7163227255_dafb74ab94_b

Alex Langford reflects on the media hype surrounding a new RCT of the NAVIGATE intervention; a comprehensive, multidisciplinary, team-based treatment approach for first episode psychosis.

[read the full story...]